Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
The high cost of medicines used to treat neurological diseases has received considerable attention in recent years. Disease‐modifying drugs for multiple sclerosis are expensive, and the cost‐effectiveness of these drugs has been discussed in the USA and the European Union. In Japan, the cost of multiple sclerosis therapies has increased gradually.
The high cost of medicines used to treat neurological diseases has received considerable attention in recent years. Disease‐modifying drugs for multiple sclerosis are expensive, and the cost effectiveness of these drugs has been discussed in the US and EU. In Japan, the costs of multiple sclerosis therapies has increased gradually.